David Sabatini
Mentioned as a researcher familiar with mTOR, alongside Matt Kaeberlein.
Build a pod of every appearance and mention of David Sabatini.
18 videos discussing or featuring David Sabatini. Save them to your own pod, ask any question across them, and connect it to Claude or ChatGPT.
Common Themes
Videos Mentioning David Sabatini

357 ‒ A new era of longevity science: models of aging, rapamycin trials, biological clocks, & more
Peter Attia MD
Mentioned as a researcher familiar with mTOR, alongside Matt Kaeberlein.

175 - The biology of aging, rapamycin, and other interventions that target the aging process
Peter Attia MD
A leading researcher in the mTOR field, mentioned in the context of developing a model for rapamycin's side effects being due to chronic mTORC2 inhibition, and as someone to consult regarding Torin 2's discovery.

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging
Peter Attia MD
A prominent scientist in the field of mTOR research, credited with identifying mTOR in mammals and elucidating its two different complexes (TORC1 and TORC2).

#114 – Eileen White, Ph.D.: Autophagy, fasting, and promising new cancer therapies
Peter Attia MD
David Sabatini introduced Peter Attia and Eileen White a few years prior to the podcast, and his work on ribosomal RNA and ribophagy is mentioned.

#112 – Ned David, Ph.D.: How cellular senescence influences aging, and what we can do about it
Peter Attia MD
Scientist whose work linked calorie restriction to Rapamycin, identifying mTOR as a common control knob for longevity.

Dr. Peter Attia — Longevity Drugs, Alzheimer's Disease, and More
Tim Ferriss
The first person to identify how Rapamycin worked in mammals, a key figure in mTOR research.

#103 – Looking back on the first 99 episodes: Strong Convictions, Loosely Held
Peter Attia MD
An expert interviewed on the podcast regarding Rapamycin and mTOR.

#31 – Navdeep Chandel, Ph.D.: metabolism, mitochondria, and metformin in health and disease
Peter Attia MD
A mutual friend and colleague mentioned as having traveled to Easter Island with Peter Attia and Navdeep Chandel, and also discussed in relation to mTOR.

#27 – David Sinclair, Ph.D.: Slowing aging – sirtuins, NAD, and the epigenetics of aging
Peter Attia MD
A mutual friend who introduced Peter Attia and David Sinclair, famous for his work on mTOR.

#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?
Peter Attia MD
An investigator who independently stumbled upon the discovery of the mitochondrial folate pathway being dramatically upregulated in cancer.

#10 – Matt Kaeberlein, Ph.D.: rapamycin and dogs — living longer, healthier & turning back the clock
Peter Attia MD
Renowned researcher known for his work on mTOR and rapamycin, who introduced Peter Attia to Matt Kaeberlein.

Supplements for Longevity & Their Efficacy | Dr. Peter Attia
Andrew Huberman
Colleague of Matt Kaeberlein, mentioned in the context of early sirtuin research and a trip to Easter Island.

Dr. Andrew Huberman — A Neurobiologist on Sleep, Performance, and Anxiety | The Tim Ferriss Show
Tim Ferriss
A genius researcher from MIT, known for his work with mTOR.

#02 – Rhonda Patrick, Ph.D.: paradox of IGF-1, ketogenic diets and genetics, benefits of sauna, NAD+
Peter Attia MD
A scientist specializing in fundamental aspects of metabolism and cellular growth, mentioned for his work and his recent visit to San Diego.

"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)
Peter Attia MD
Mentioned as a past podcast guest discussing aging.

Outlive: The Science and Art of Longevity — Dr. Peter Attia
Tim Ferriss
A mutual friend of Peter and Tim, whose lab research highlighted leucine as a potent mTOR stimulator.

Valter Longo, Ph.D. on Fasting-Mimicking Diet & Fasting for Longevity, Cancer & Multiple Sclerosis
FoundMyFitness
Researcher whose work on fat and fatty acids in stem cell renewal was mentioned.

222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D.
Peter Attia MD
A researcher with whom the host and guest had a discussion about the timing and frequency of Rapamycin dosing.